OKKO Health

Okulo Ltd. is a Bristol-based company focused on innovative eye care solutions using smartphone technology for self-monitoring eye diseases, enhancing clinic efficiency and patient engagement. Founded in 2018 in Bristol, UK, Okulo Ltd. specializes in eye care solutions.

The company has received GBP 2 million in funding during a deal on December 27, 2021, led by Dieter von Holtzbrinck Ventures, with other investors including Bristol Private Equity Club and Plug and Play Ventures. Stephanie Campbell serves as both the founder and CEO. OKKO Health specializes in innovative eye care solutions that enhance clinic efficiency and ensure timely treatment through smartphone-based self-monitoring technology. The flagship product, OKKO, employs simple puzzle games designed with vision science principles to facilitate self-monitoring of eye diseases, particularly Age-related Macular Degeneration (AMD).

This product allows patients to assess their vision from the comfort of home, promoting early detection and immediate action when vision deterioration occurs. OKKO Health primarily serves patients diagnosed with eye conditions and eye care professionals, including ophthalmologists and optometrists, across various geographical markets such as the United Kingdom and parts of Europe, where there is a growing demand for remote health monitoring solutions. OKKO Health's revenue model is centered on direct-to-consumer and B2B partnerships, offering subscriptions for its self-monitoring services. Clients, including healthcare providers and individual patients, can engage with the platform through a subscription model, which provides ongoing access to the self-monitoring technology and associated resources.

The revenue structure often involves tiered pricing plans catering to different user needs, enabling healthcare providers to integrate the service into their practices efficiently. In December 2021, Okulo Ltd. raised GBP 2 million in a pre-seed round led by Dieter von Holtzbrinck Ventures, which will be used to launch its product in Germany and accelerate its global growth. The company plans to expand its market presence in Europe, targeting additional regions with a growing need for remote eye care solutions.

In July 2025, Okko Health raised an undisclosed amount of seed funding led by new investor Topcon Healthcare.